97 related articles for article (PubMed ID: 209810)
21. Clinical phase I study of the hypoxic cell radiosensitizer RO-07-0582, a 2-nitroimidazole derivative.
Urtasun RC; Band P; Chapman JD; Rabin HR; Wilson AF; Fryer CG
Radiology; 1977 Mar; 122(3):801-4. PubMed ID: 841074
[TBL] [Abstract][Full Text] [Related]
22. The response of human tumour metastases to radiation and misonidazole.
Dawen PJ; Peckham MJ; Steel GG
Br J Cancer Suppl; 1978 Jun; 3():290-6. PubMed ID: 277247
[TBL] [Abstract][Full Text] [Related]
23. Phase I trial of intravenous L-phenylalanine mustard plus the sensitizer misonidazole.
Coleman CN; Friedman MK; Jacobs C; Halsey J; Ignoffo R; Leibel S; Hirst VK; Gribble M; Carter SK; Phillips TL
Cancer Res; 1983 Oct; 43(10):5022-5. PubMed ID: 6883348
[TBL] [Abstract][Full Text] [Related]
24. Effect of misonidazole on formation of thymine damage by gamma rays.
Remsen JF
Radiat Res; 1985 Feb; 101(2):306-11. PubMed ID: 3975359
[TBL] [Abstract][Full Text] [Related]
25. Final report of the phase I trial of the hypoxic cell radiosensitizer SR 2508 (etanidazole) Radiation Therapy Oncology Group 83-03.
Coleman CN; Wasserman TH; Urtasun RC; Halsey J; Noll L; Hancock S; Phillips TL
Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):389-93. PubMed ID: 2154420
[TBL] [Abstract][Full Text] [Related]
26. Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses.
Dische S; Saunders MI; Lee ME; Adams GE; Flockhart IR
Br J Cancer; 1977 May; 35(5):567-79. PubMed ID: 861146
[TBL] [Abstract][Full Text] [Related]
27. Dose-response curves for predicting misonidazole-induced peripheral neuropathy.
Schwade JG; Makuch RW; Strong JM; Glatstein E
Cancer Treat Rep; 1982 Sep; 66(9):1743-50. PubMed ID: 6288238
[TBL] [Abstract][Full Text] [Related]
28. [Radiosensitizer: hypoxic cell radiosensitizer].
Mori T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1399-404. PubMed ID: 2525001
[TBL] [Abstract][Full Text] [Related]
29. Preliminary results of RTOG phase I/II study of misonidazole and radiation for bladder cancer.
Mohiuddin M; Kramer S; Phillips T; Soberon M; Forgione H
Am J Clin Oncol; 1982 Oct; 5(5):551-4. PubMed ID: 7180834
[TBL] [Abstract][Full Text] [Related]
30. [Clinical evaluation of hypoxic cell sensitizer (Misonidazole)].
Asakawa H; Watarai J; Hoshino T
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1225-30. PubMed ID: 6732250
[TBL] [Abstract][Full Text] [Related]
31. [Development of new hypoxic cell radiosensitizer in Japan].
Mori T; Murayama C
Gan No Rinsho; 1988 Oct; 34(13):1869-74. PubMed ID: 2974089
[TBL] [Abstract][Full Text] [Related]
32. Radiosensitization in multifraction schedules. II. Greater sensitization by 2-nitroimidazoles than by oxygen.
Taylor YC; Brown JM
Radiat Res; 1987 Oct; 112(1):134-45. PubMed ID: 3659294
[TBL] [Abstract][Full Text] [Related]
33. [Clinical trials of hypoxic cell sensitizer misonidazole].
Onoyama Y
Gan No Rinsho; 1983 May; 29(6):718-25. PubMed ID: 6348345
[TBL] [Abstract][Full Text] [Related]
34. Misonidazole neuropathy.
Paulson OB; Melgaard B; Hansen HS; Kamieniecka Z; Køhler O; Hansen JM; Pedersen AG; Tang X; Trojaborg W
Acta Neurol Scand Suppl; 1984; 100():133-6. PubMed ID: 6091392
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of hypoxic cell radiosensitizers: a review.
Workman P
Cancer Clin Trials; 1980; 3(3):237-51. PubMed ID: 7438321
[TBL] [Abstract][Full Text] [Related]
36. A preliminary clinical study in the use of misonidazole in cancer of the head and neck.
Sealy R
Br J Cancer Suppl; 1978 Jun; 3():314-7. PubMed ID: 277253
[TBL] [Abstract][Full Text] [Related]
37. Phase I trial of the hypoxic cell radiosensitizer SR-2508: the results of the five to six week drug schedule.
Coleman CN; Wasserman TH; Urtasun RC; Halsey J; Hirst VK; Hancock S; Phillips TL
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1105-8. PubMed ID: 3017904
[TBL] [Abstract][Full Text] [Related]
38. The effect of misonidazole in combination with radiation dose fractionation.
Hill RP; Bush RS
Br J Cancer Suppl; 1978 Jun; 3():255-8. PubMed ID: 277242
[TBL] [Abstract][Full Text] [Related]
39. [Clinical experiences with the radiation-sensitizing agent misonidazole].
Kogelnik HD; Szepesi T; Kärcher KH; Seitz W
Strahlentherapie Sonderb; 1978; 75():115-9. PubMed ID: 162327
[No Abstract] [Full Text] [Related]
40. A phase I study of the hypoxic cell radiosensitizer Ro-03-8799.
Roberts JT; Bleehen NM; Workman P; Walton MI
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1755-8. PubMed ID: 6480458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
